Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 11
Original Research
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,464 | Dovepress* | 6,606+ | 1,653 | 8,259 | |
| PubMed Central* | 858 | 226 | 1,084 | ||
| Totals | 7,464 | 1,879 | 9,343 | ||
| *Since 27 December 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar